TESAURO, MANFREDI
 Distribuzione geografica
Continente #
NA - Nord America 45.790
AS - Asia 5.546
EU - Europa 4.902
SA - Sud America 831
Continente sconosciuto - Info sul continente non disponibili 593
AF - Africa 142
OC - Oceania 41
Totale 57.845
Nazione #
US - Stati Uniti d'America 45.539
SG - Singapore 2.211
IT - Italia 1.027
CN - Cina 1.024
BR - Brasile 698
RU - Federazione Russa 645
DE - Germania 609
UA - Ucraina 543
HK - Hong Kong 536
IE - Irlanda 404
VN - Vietnam 400
FR - Francia 391
GB - Regno Unito 289
IN - India 282
PL - Polonia 240
BD - Bangladesh 233
FI - Finlandia 221
SE - Svezia 206
KR - Corea 188
JP - Giappone 154
CA - Canada 134
NL - Olanda 94
ID - Indonesia 75
IR - Iran 74
TR - Turchia 64
PK - Pakistan 59
AR - Argentina 45
MX - Messico 42
BE - Belgio 40
EG - Egitto 37
ZA - Sudafrica 36
ES - Italia 32
IQ - Iraq 31
AU - Australia 28
CZ - Repubblica Ceca 25
PH - Filippine 25
SA - Arabia Saudita 25
TH - Thailandia 24
MY - Malesia 23
CO - Colombia 21
EC - Ecuador 21
UZ - Uzbekistan 20
AE - Emirati Arabi Uniti 19
AT - Austria 18
PR - Porto Rico 18
RO - Romania 18
VE - Venezuela 16
LT - Lituania 15
MA - Marocco 15
NZ - Nuova Zelanda 13
PT - Portogallo 13
KG - Kirghizistan 12
NP - Nepal 12
TW - Taiwan 12
CL - Cile 10
EU - Europa 10
HN - Honduras 10
KE - Kenya 10
AL - Albania 9
CR - Costa Rica 9
CH - Svizzera 8
DK - Danimarca 8
IL - Israele 8
JM - Giamaica 8
NG - Nigeria 8
NI - Nicaragua 8
RS - Serbia 8
TN - Tunisia 8
DZ - Algeria 7
GR - Grecia 7
KZ - Kazakistan 7
PE - Perù 7
PY - Paraguay 7
GT - Guatemala 6
AZ - Azerbaigian 5
BG - Bulgaria 5
EE - Estonia 4
JO - Giordania 4
MT - Malta 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
GH - Ghana 3
HU - Ungheria 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TZ - Tanzania 3
XK - ???statistics.table.value.countryCode.XK??? 3
A1 - Anonimo 2
BF - Burkina Faso 2
BN - Brunei Darussalam 2
BZ - Belize 2
CY - Cipro 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
GE - Georgia 2
HR - Croazia 2
LB - Libano 2
Totale 57.234
Città #
Woodbridge 12.200
Wilmington 10.641
Houston 9.972
Fairfield 1.420
Singapore 1.332
Ashburn 1.269
Ann Arbor 876
Chandler 798
San Jose 660
Seattle 557
Hong Kong 494
Jacksonville 466
Cambridge 430
New York 367
Dublin 354
Beijing 347
Rome 337
Dearborn 305
Council Bluffs 301
Medford 293
Kraków 204
Santa Clara 197
Los Angeles 191
The Dalles 150
Lawrence 135
Tokyo 130
Ho Chi Minh City 126
Dallas 123
Lauterbourg 112
Hanoi 94
Moscow 92
Menlo Park 91
Buffalo 89
Zhengzhou 89
São Paulo 74
San Diego 73
Helsinki 70
Milan 70
London 60
Denver 55
Munich 52
Atlanta 51
Orem 45
Saint Petersburg 45
Chicago 43
North Bergen 43
Shanghai 41
Montreal 40
Phoenix 40
Mülheim 38
Frankfurt am Main 36
Norwalk 36
Redondo Beach 35
Brooklyn 33
Hefei 33
Nuremberg 33
Boardman 32
Brussels 31
Chennai 31
Jakarta 31
Columbus 30
Lahore 27
Manchester 27
San Francisco 27
Toronto 27
Warsaw 27
Falls Church 26
Guangzhou 24
Johannesburg 24
Palo Alto 24
Nanjing 23
Rio de Janeiro 21
Mountain View 20
Nürnberg 20
Seoul 20
Naples 19
Tehran 19
Amsterdam 18
Boston 18
Engelhard 18
Miami 18
Redwood City 18
Washington 18
Detroit 17
Mexico City 17
Stockholm 17
Brasília 16
Brno 16
Haiphong 16
Lappeenranta 16
Salt Lake City 16
Turku 16
Bangkok 15
Poplar 15
Baghdad 14
Bayamón 14
Bologna 14
Istanbul 14
Jinan 14
New Delhi 14
Totale 47.187
Nome #
Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance 644
Peroxiredoxin 6, a novel player in the pathogenesis of diabetes 621
Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome 552
Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients 542
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy 535
Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology 533
Involvement of PRDX6 in the pathogenesis of obesity and nonalcoholic fatty liver disease 533
Concomitant impairment in endothelial function and neural cardiovascular regulation in offspring of type 2 diabetic subjects 517
Concomitant impairment in endothelial function and neural cardiovascular regulation in offspring of type 2 diabetic subjects 507
Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy 504
The possible role of glutathione-S-transferase activity in diabetic nephropathy 504
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy 501
Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: Relations with eating patterns and circulating concentrations of cortisol and thyroid hormones 497
Analysis of the power of common diagnostic tools in the management of acute pancreatitis 496
Decreased plasma adiponectin concentration in major depression 496
Insulin glargine in enteric tube feeding. 495
SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α 494
Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol 493
Arterial ageing: from endothelial dysfunction to vascular calcification 491
Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: novel targets for treatment 488
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 487
The possible role of physical activity in the modulation of gut microbiota in chronic kidney disease and its impact on cardiovascular risk: a narrative review 485
Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects 485
Impact of Mediterranean diet on metabolic syndrome, cancer and longevity 483
Preoperative embolization reduces the risk of cathecolamines release at the time of surgical excision of large pelvic extra-adrenal sympathetic paraganglioma 477
Obesity and kidney disease: Beyond the hyperfiltration 477
Ghrelin improves endothelial function in patients with metabolic syndrome 475
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 473
Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia 473
Sildenafil reduces insulin-resistance in human endothelial cells 472
Preventive geriatrics the cross-talk between arterial and brain aging: A lifelong condition 471
Plasma Ghrelin in Anorexia, Bulimia, and Binge-Eating Disorder: Relations with Eating Patterns and Circulating Concentrations of Cortisol and Thyroid Hormones 467
Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual 459
Immune reaction and colorectal cancer: friends or foes? 459
Helicobacter pylori infection associates with a mucosal downregulation of Ghrelin, negative regulator of Th1-cell responses 459
Erythrocyte glutathione transferase activity: a possible early biomarker for blood toxicity in uremic diabetic patients 458
Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients 457
Vasodilator Responses and Endothelin-Dependent Vasoconstriction in Metabolically Healthy Obesity and the Metabolic Syndrome 457
Gut hormones and endothelial dysfunction in patients with obesity and diabetes 453
Reduction of left ventricular hypertrophy detected by cardiac magnetic resonance in a patient after renal denervation 453
"The Linosa Study": Epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate 453
Aortic stiffness and hypotension episodes are associated with impaired cognitive function in older subjects with subjective complaints of memory loss 452
Tumor necrosis factor-α antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome 451
Beneficial Effects of Apelin on Vascular Function in Patients with Central Obesity 451
Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome 449
Obesity, blood vessels and metabolic syndrome 449
Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes 448
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298 447
Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome 447
Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans 447
[Endothelial dysfunction and diabetes: possible role in kidney damage] 447
Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome 447
Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol 447
Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus 446
Decreased plasma adiponectin concentration in major depression 445
Cardiovascular and metabolic effects of ghrelin 444
Occurrence of Hypotension in Older Participants. Which 24-hour ABPM Parameter Better Correlate With? 441
Recent acquisitions on the pathophysiology of metabolic syndrome [Recenti progressi nelle conoscenze della patogenesi della sindrome metabolica] 438
Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes 436
Human obesity and endothelium-dependent responsiveness 436
Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study 436
Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes 434
Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells 431
Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome 431
Clinical and electrical performance of currently available MRI-safe pacing systems. Do all devices perform in the same way? 429
Ghrelin improves endothelial function in patients with metabolic syndrome 429
CD26: a multi-purpose pharmacological target 427
Insulinemia and the risk of breast cancer and its relapse 425
Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells 424
Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome 423
Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study 423
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 422
Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome 421
Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome. 418
The Linosa Study: epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate 417
Metabolic and cardiovascular effects of ghrelin 417
Management of global cardiovascular risk in older subjects with diabetes mellitus 417
Vascular effects of insulin and their relation to endothelial dysfunction, insulin resistance and hypertension 417
Obesity-related metabolic syndrome and vascular complications. 416
PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia. 415
Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome 415
Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual 415
Early detection of high voltage lead failure with an unusual and unexpected device alert 414
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease 413
The vascular endothelin system in obesity and type 2 diabetes: Pathophysiology and therapeutic implications 413
Chronic kidney disease, obesity, and hypertension: the role of leptin and adiponectin 411
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 411
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease. 410
Unexplained syncope in a patient with Brugada-like electrocardiogram. Lighting the dark side of underlying bradyarrhythmias 410
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 409
[Diabetes worsens the clinical manifestations and prognosis of concurrent cardiovascular and kidney disease] 408
Obesity, inflammation and endothelial dysfunction 406
Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus 402
Nox2 is determinant for ischemia-induced oxidative stress and arterial vasodilatation: a pilot study in patients with hereditary Nox2 deficiency 402
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients 400
Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines 399
Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells 394
Vascular Effects of Obestatin in Lean and Obese Subjects 394
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B) 390
Insulin glargine in enteric tube feeding 389
Totale 45.321
Categoria #
all - tutte 135.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.277 0 0 0 69 69 154 116 97 129 129 98 416
2022/20231.973 174 188 89 225 154 410 180 133 174 18 125 103
2023/20241.251 123 63 78 47 100 317 174 71 25 83 48 122
2024/20253.773 164 699 383 307 214 233 274 221 390 355 312 221
2025/20266.677 549 341 769 580 641 177 916 706 724 651 341 282
2026/20272.519 610 357 1.192 360 0 0 0 0 0 0 0 0
Totale 57.845